Cargando…
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species
Several promising antimalarial drugs are currently being tested in human trials, such as artefenomel, cipargamin, ferroquine and ganaplacide. Many of these compounds were identified using high throughput screens against a single species of human malaria, Plasmodium falciparum, under the assumption t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327131/ https://www.ncbi.nlm.nih.gov/pubmed/34315108 http://dx.doi.org/10.1016/j.ijpddr.2021.07.002 |